Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Cassava Sciences expects to release ... I believe that Phase 3 failure could see the stock trading near its book value. In Q3, Cassava spent $17.676 million on R&D and $12.947 million on G&A.

Piper Sandler reiterated its Neutral position, reflecting a watchful approach to Sight Sciences' stock amidst the current ... with a 1-week price total return of -10.17%. This recent downturn ...

Short interest in Cassava Sciences Inc (NASDAQ:SAVA) increased during the last reporting period, rising from 17.63M to 18.94M ... decline of Cassava Sciences's stock. Short interest data is ...

Alger Health Sciences Fund earns a Below Average Process ... However, following the post-covid stock rally, Alger, like many growth-centric active managers, experienced disappointing results ...

The company’s shares closed last Thursday at $17.25, close to its 52-week low of $ ... LifeSci Capital also maintained a Buy rating on the stock with a $55.00 price target. Sight Sciences NewsMORE ...

Indian stock markets crashed on Monday ... Sciences Nirma Ltd. to launch a Rs 1,343.05 crore open offer to acquire an additional 17.33% stake in Glenmark Life Sciences Ltd. The offer opens on February ...

Partially offsetting the gain are additional expenses relating to salaries and benefits expense and increased stock-based incentives ... Campus Operations Segment revenue increased $46.6 million, or ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Headquartered in Foster City, California, Gilead Sciences, Inc. (GILD ... Among the 27 analysts covering the stock, the consensus estimate is a “Moderate Buy” overall. That’s based on ...

Shares of Maravai LifeSciences (NASDAQ:MRVI) plunged 39% Friday, the day after the company issued a Q3 earnings report and updated revenue forecast that fell short of Street expectations. After ...